Clinical Trials Browser

Sarcoma × talimogene laherparepvec × 30 days × Clear all

NCT02923778 2026-03-19

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Phase 2 Active not recruiting

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous